|
||
-dependent Internalization of the Chemokine
Receptor CXCR4 Contributes to Inhibition of
HIV Replication
By



From the * Unité d'Immunologie Virale and Ligation of CCR5 by the CC chemokines RANTES, MIP-1
Laboratoire Rétrovirus et Transfert Génétique, Institut
Pasteur, 75724 Paris, Cedex 15, France; § Laboratoire Mécanismes Moléculaires du Transport
Intracellulaire, Centre National de la Recherche Scientifique UMR 144, Institut Curie, 75248 Paris
Cedex 05, France;
Laboratoire d'Immunologie Cellulaire, Centre National de la Recherche
Scientifique URA 625, CERVI, 75013 Paris, France; and ¶ Theodor Kocher Institute, University of
Bern, CH-3000 Bern 9, Switzerland
or MIP-1
, and of CXCR4 by
the CXC chemokine SDF-1
, profoundly inhibits the replication of HIV strains that use these
coreceptors for entry into CD4+ T lymphocytes. The mechanism of entry inhibition is not
known. We found a rapid and extensive downregulation of CXCR4 by SDF-1
and of
CCR5 by RANTES or the antagonist RANTES(9-68). Confocal laser scanning microscopy
showed that CCR5 and CXCR4, after binding to their ligands, are internalized into vesicles
that qualify as early endosomes as indicated by colocalization with transferrin receptors. Internalization was not affected by treatment with Bordetella pertussis toxin, showing that it is independent of signaling via Gi-proteins. Removal of SDF-1
led to rapid, but incomplete surface
reexpression of CXCR4, a process that was not inhibited by cycloheximide, suggesting that
the coreceptor is recycling from the internalization pool. Deletion of the COOH-terminal, cytoplasmic domain of CXCR4 did not affect HIV entry, but prevented SDF-1
-induced receptor downregulation and decreased the potency of SDF-1
as inhibitor of HIV replication.
Our results indicate that the ability of the coreceptor to internalize is not required for HIV entry, but contributes to the HIV suppressive effect of CXC and CC chemokines.
This article has been cited by other articles:
| TABLE OF CONTENTS |
|